Lessons learned to better prepare for and respond to viral outbreaks with Ed Kelley, PhD
We’re only going to see more, not fewer, viral outbreaks due to several factors including:-The end of vaccination programs for diseases that have been eradic…
We’re only going to see more, not fewer, viral outbreaks due to several factors including:-The end of vaccination programs for diseases that have been eradic…
Fierce Healthcare reporters returned from Las Vegas on Wednesday after four days packed with meetings, interviews and on-stage conversations all focused on healthcare innovation. |…
The outcome of the upcoming presidential election could affect the number of insured Americans, the fate of premium-reducing subsidies, the shape of Medicaid, and the…
Sam Chang interviews Edward Messing about his research on using apalutamide for non-muscle invasive bladder cancer. Dr. Messing discusses a trial aiming to explore whether…
The revision comes after ongoing controversy surrounding the disclosure of clinical trial work and lobbying to push for greater oversight.
Nationwide findings mirror those from research after Texas banned early pregnancy abortion
ASH Clinical News Editor-in-Chief Aaron Gerds, MD, previews what’s to come in November. Highlights include a feature on managing substance use disorders in p…
Prostate Cancer, Biochemical Recurrence of Prostate Cancer, gastrin-releasing peptide receptor (GRPR), gastrin-releasing peptide receptor antagonist 68Ga-RM2, gastrin-releasing peptide receptor antagonist, 68Ga-RM2 PET-MRI, gastrin-releasing peptide receptor-targeted…
The body’s cooling defenses fail at lower “wet bulb” temperatures than scientists had estimated.
Forecasters will soon be able to use the instrument, a coronagraph, to better monitor the effects of solar storms.
We are thrilled to share our new season of the Johns Hopkins Center for Health Equity (CHE) Jam Sessions! CHE invites speakers from a variety of research…